The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 10K | $0.98 | $10K |
| Aug 3, 2026 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 75K | $0.94 | $71K |
| Jun 3, 2026 | Sapirstein James | Chief Executive Officer | Grant(A) | 235K | — | $0 |
| Feb 24, 2026 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 20K | $1.00 | $20K |
| Feb 6, 2026 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 50K | $0.95 | $48K |
| Jan 9, 2026 | Rubin Steven D | Director | Grant(A) | 16K | — | $0 |
| Jan 9, 2026 | Japour Anthony J | Director | Grant(A) | 16K | — | $0 |
| Jan 9, 2026 | Frost Phillip MD Et Al | Director, 10% Owner | Grant(A) | 25K | — | $0 |
| Jan 9, 2026 | Martin James Joseph | Co-CEO and CFO | Grant(A) | 49K | — | $0 |
| Jan 9, 2026 | Hassan Fred | Director | Grant(A) | 16K | — | $0 |
| Jan 9, 2026 | Lee Sam | President and Co-CEO | Grant(A) | 49K | — | $0 |
| Jan 9, 2026 | Pfenniger Richard C JR | Director | Grant(A) | 16K | — | $0 |
| Jan 9, 2026 | Kornberg Roger D. | Director | Grant(A) | 25K | — | $0 |
| Dec 31, 2025 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 50K | $0.95 | $48K |
| Dec 30, 2025 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 20K | $0.97 | $19K |
| Dec 26, 2025 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 40K | $0.97 | $39K |
| Dec 24, 2025 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 25K | $0.97 | $24K |
| Nov 26, 2025 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 3K | $0.99 | $2K |
| Nov 26, 2025 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 2K | $1.00 | $2K |
| Nov 25, 2025 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 20K | $0.94 | $19K |
| Oct 28, 2025 | Martin James Joseph | Co-CEO and CFO | Grant(A) | 4K | $1.39 | $5K |
| Oct 28, 2025 | Martin James Joseph | Co-CEO and CFO | Grant(A) | 7K | $1.39 | $10K |
| Oct 28, 2025 | Pfenniger Richard C JR | Director | Grant(A) | 20K | — | — |
| Oct 28, 2025 | Pfenniger Richard C JR | Director | Grant(A) | 40K | $1.39 | $56K |
| Oct 28, 2025 | Hassan Fred | Director | Grant(A) | 360K | $1.39 | $500K |
| Oct 28, 2025 | Hassan Fred | Director | Grant(A) | 719K | $1.39 | $1.0M |
| Oct 28, 2025 | Frost Phillip MD Et Al | Director, 10% Owner | Grant(A) | 360K | $1.39 | $500K |
| Oct 28, 2025 | Frost Phillip MD Et Al | Director, 10% Owner | Grant(A) | 719K | $1.39 | $1.0M |
| Oct 9, 2024 | Japour Anthony J | Director | Grant(A) | 15K | — | — |
| Oct 9, 2024 | Hassan Fred | Director | Grant(A) | 8K | — | — |
| Oct 9, 2024 | Martin James Joseph | Co-CEO and CFO | Grant(A) | 40K | — | — |
| Oct 9, 2024 | Frost Phillip MD Et Al | Director, 10% Owner | Grant(A) | 27K | — | — |
| Oct 9, 2024 | Pfenniger Richard C JR | Director | Grant(A) | 8K | — | — |
| Oct 9, 2024 | Kornberg Roger D. | Director | Grant(A) | 28K | — | — |
| Oct 9, 2024 | Lee Sam | President and Co-CEO | Grant(A) | 40K | — | — |
| Oct 9, 2024 | Rubin Steven D | Director | Grant(A) | 19K | — | — |
| Jul 18, 2023 | Rubin Steven D | Director | Grant(A) | 17K | — | $0 |
| Jul 18, 2023 | Hassan Fred | Director | Grant(A) | 7K | — | $0 |
| Jul 18, 2023 | Pfenniger Richard C JR | Director | Grant(A) | 7K | — | $0 |
| Jul 18, 2023 | Lee Sam | President and Co-CEO | Grant(A) | 30K | — | $0 |
| Jul 18, 2023 | Kornberg Roger D. | Director | Grant(A) | 24K | — | $0 |
| Jul 18, 2023 | Martin James Joseph | Co-CEO and CFO | Grant(A) | 30K | — | $0 |
| Jul 18, 2023 | Japour Anthony J | Director | Grant(A) | 14K | — | $0 |
| Jul 18, 2023 | Frost Phillip MD Et Al | Director, 10% Owner | Grant(A) | 19K | — | $0 |
| Apr 4, 2023 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 1.0M | $1.97 | $2.0M |
| Jul 25, 2022 | Kornberg Roger D. | Director | Grant(A) | 280K | — | $0 |
| Jul 25, 2022 | Lee Sam | President and Co-Interim CEO | Grant(A) | 300K | — | $0 |
| Jul 25, 2022 | Rubin Steven D | Director | Grant(A) | 188K | — | $0 |
| Jul 25, 2022 | Martin James Joseph | Co- Interim CEO and CFO | Grant(A) | 300K | — | $0 |
| Jul 25, 2022 | Pfenniger Richard C JR | Director | Grant(A) | 80K | — | $0 |
| Jul 25, 2022 | Frost Phillip MD Et Al | Director | Grant(A) | 220K | — | $0 |
| Jul 25, 2022 | Japour Anthony J | Director | Grant(A) | 148K | — | $0 |
| Aug 20, 2021 | Pfenniger Richard C JR | Director | Buy(P) | 40K | $1.03 | $41K |
| Jul 16, 2021 | Japour Anthony J | Director | Grant(A) | 74K | — | $0 |
| Jul 16, 2021 | Pfenniger Richard C JR | Director | Grant(A) | 50K | — | $0 |
| Jul 16, 2021 | Rubin Steven D | Director | Grant(A) | 88K | — | $0 |
| Jul 16, 2021 | Martin James Joseph | Chief Financial Officer | Grant(A) | 250K | — | $0 |
| Jul 16, 2021 | Kornberg Roger D. | Director | Grant(A) | 65K | — | $0 |
| Jul 16, 2021 | Frost Phillip MD Et Al | Director | Grant(A) | 65K | — | $0 |
| Jul 16, 2021 | Lee Sam | President and Co-Interim CEO | Grant(A) | 250K | — | $0 |
| May 4, 2021 | Schinazi Raymond F | 10% Owner | Sell(S) | 575K | $2.95 | $1.7M |
| Jun 22, 2020 | Lee Sam | President | Grant(A) | 100K | — | $0 |
| Jun 22, 2020 | Japour Anthony J | Director | Grant(A) | 56K | — | $0 |
| Jun 22, 2020 | Wilcox Gary | Chief Executive Officer | Grant(A) | 200K | — | $0 |
| Jun 22, 2020 | Kornberg Roger D. | Director | Grant(A) | 50K | — | $0 |
| Jun 22, 2020 | Martin James Joseph | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Jun 22, 2020 | Frost Phillip MD Et Al | Director | Grant(A) | 50K | — | $0 |
| Jun 22, 2020 | Rubin Steven D | Director | Grant(A) | 72K | — | $0 |
| Oct 25, 2019 | Schinazi Raymond F | 10% Owner | Buy(P) | 8K | $1.15 | $9K |
| Oct 24, 2019 | Schinazi Raymond F | 10% Owner | Buy(P) | 5K | $1.15 | $6K |
| Oct 23, 2019 | Schinazi Raymond F | 10% Owner | Buy(P) | 4K | $1.04 | $4K |
| Sep 21, 2018 | Hsiao Jane PH D | Director | Grant(A) | 50K | — | $0 |
| Sep 21, 2018 | Lee Sam | President | Grant(A) | 100K | — | $0 |
| Sep 21, 2018 | Rubin Steven D | Director | Grant(A) | 50K | — | $0 |
| Sep 21, 2018 | Frost Phillip MD Et Al | Director, 10% Owner | Grant(A) | 50K | — | $0 |
| Sep 21, 2018 | Schinazi Raymond F | Director, 10% Owner | Grant(A) | 50K | — | $0 |
| Sep 21, 2018 | Block David S | Director | Grant(A) | 50K | — | $0 |
| Sep 21, 2018 | Wilcox Gary | Interim CEO, Director | Grant(A) | 200K | — | $0 |
| Sep 21, 2018 | Martin James Joseph | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| May 10, 2018 | Schinazi Raymond F | Director, 10% Owner | Disposed to issuer(D) | 62K | $500,000.00as filed | — |
| May 10, 2018 | Schinazi Raymond F | Director, 10% Owner | Grant(A) | 263K | $500,000.00as filed | — |
| May 10, 2018 | Schinazi Raymond F | Director, 10% Owner | Option exercise(M) | 263K | $500,000.00as filed | — |
| May 10, 2018 | Schinazi Raymond F | Director, 10% Owner | Option exercise(M) | 263K | $1.90 | $500K |
| May 10, 2018 | Schinazi Raymond F | Director, 10% Owner | Grant(A) | 10K | $1.90 | $19K |
| May 3, 2018 | Schinazi Raymond F | Director, 10% Owner | Grant(A) | 421K | $1.90 | $799K |
| May 3, 2018 | Frost Phillip MD Et Al | Director, 10% Owner | Grant(A) | 105K | $1.90 | $200K |
| Nov 24, 2017 | Schinazi Raymond F | Director | Grant(A) | 1.9M | $500,000.00as filed | — |
| Jul 11, 2017 | Schinazi Raymond F | Director, 10% Owner | Option exercise(M) | 1.7M | — | $0 |
| Jul 11, 2017 | Schinazi Raymond F | Director, 10% Owner | Option exercise(M) | 1.7M | $0.05 | $85K |
| Apr 20, 2017 | Schinazi Raymond F | Director, 10% Owner | Grant(A) | 4.2M | $0.24 | $1.0M |
| Dec 23, 2016 | Lee Sam | PRESIDENT | Sell(S) | 2.2M | $0.44 | $968K |
| Sep 1, 2016 | Block David S | Director | Buy(P) | 10K | $0.41 | $4K |
| Sep 1, 2016 | Schinazi Raymond F | Director, 10% Owner | Buy(P) | 4.9M | $0.41 | $2.0M |
| Sep 1, 2016 | Wilcox Gary | INTERIM CEO, Director | Buy(P) | 10K | $0.41 | $4K |
| Mar 15, 2016 | Rubin Steven D | Director | Buy(P) | 39K | $0.51 | $20K |
| Mar 15, 2016 | Frost Phillip MD Et Al | Director, 10% Owner | Buy(P) | 2.9M | $0.51 | $1.5M |
| Mar 15, 2016 | Meckler Jeffrey A | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 294K | $0.51 | $150K |
| Mar 15, 2016 | Block David S | Director | Buy(P) | 50K | $0.51 | $26K |
| Mar 15, 2016 | Wilcox Gary | Director | Buy(P) | 49K | $0.51 | $25K |
| Mar 15, 2016 | Schinazi Raymond F | Director, 10% Owner | Buy(P) | 2.9M | $0.51 | $1.5M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Cocrystal Pharma, Inc., SEC CIK 0001412486. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under COCP and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for COCP